Oxadiazolones as transient receptor potential channel inhibitors
The invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as respiratory disorders or pain. 
Genentech, Inc.
C A C A A A A A A A A A A A C C C A A
C07D A61P C07D A61P A61P A61P A61K A61P A61P A61P A61P A61P A61P A61P C07D C07D C07D A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Robin Stuart Baihua Francis Andrew Huifen Martin Matthew Aijun Daniel Elisia
Larouche-Gauthier Ward Hu Beaumier Cridland Chen Dery Volgraf Lu Shore Villemure